sofosbuvir and ribavirin to treat hepatitis c virus genotype 4 infection in a 65-year-old patient with diabetes and low platelet: a case report

Introduction: hepatitis c virus (hcv) is a major public health problem especially in the elderly. the classical interferon/ribavirin regimen was unfavorable for elderly patents due to intolerability and adverse effects. more studies are needed about the safety profile of new direct-acting antiviral (daa) in the elderly. case presentation: here, a case of chronic hcv was described in a 65-year-old female with diabetes and low platelet count. the patient was treated successfully by a combination of sofosbuvir+ ribavirin without major side effects. conclusions: this report highlighted the importance and the safety of this regimen to treat hcv in the elderly.